Journal article · Research (general)← The news desk

✦ The Dispatch

Donor-Site Morbidity After Buccinator Myomucosal Flap: A Multicenter Cohort Study

A dispatch from PubMed — filed

OBJECTIVES: Buccinator myomucosal flaps (BMF) are increasingly used for reconstruction of small- to medium-sized intraoral defects because they replace oral mucosa with similar tissue. However, donor-site morbidity and its determinants remain poorly defined. This study aimed to evaluate donor-site morbidity after BMF harvest and identify factors associated with unfavorable outcomes.

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change for audiologists; this surgical study on oral reconstruction donor-site complications has minimal direct relevance to audiology practice.

✦ Why It Matters ✦

While peripheral to audiology, understanding donor-site morbidity informs head-and-neck multidisciplinary teams who sometimes overlap with audiological care in patients with oral or skull-base pathology.

✦ Key Points ✦
  1. 01Multicenter cohort study published in Laryngoscope on buccinator myomucosal flap donor-site morbidity.
  2. 02Examines complication rates (e.g., pain, sensory loss) at the harvesting site in the cheek.
  3. 03Limited direct relevance to hearing health or audiology clinical practice.
  4. 04Data from multiple centres improves generalisability of morbidity estimates.
  5. 05Findings primarily applicable to oral and maxillofacial or head-and-neck surgical teams.
✦ Claims & Evidence ✦

Buccinator myomucosal flap harvest causes measurable donor-site morbidity in patients undergoing intraoral reconstruction.

studysupported
✦ Research metadata ✦
PMID
43035386
DOI
10.1002/lary.71062.
Journal
Laryngoscope
Publication type
research_article
Evidence level
2b
Population
Patients undergoing intraoral reconstruction with buccinator myomucosal flaps across multiple centres
Intervention
Buccinator myomucosal flap harvest for intraoral reconstruction

Primary outcomes

Donor-site morbidity (pain, sensory changes, functional deficits)

✦ Related stories ✦